RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1480293
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

HOXA10 Deteriorates Gastric Cancer Through Activating JAK1/STAT3 Signaling Pathway

Cancer Management and Research
Oncology
2019English

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway

Cancer Management and Research
Oncology
2020English

H19 Induced by Oxidative Stress Confers Temozolomide Resistance in Human Glioma Cells via Activating NF-κB Signaling

OncoTargets and Therapy
OncologyPharmacology
2018English

Exosomal Transfer of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance in NSCLC Through Activating Autophagy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

Heparin Antagonizes Cisplatin Resistance of A2780 Ovarian Cancer Cells by Affecting the WNT Signaling Pathway

Oncotarget
Oncology
2017English

miRNA‑328 Overexpression Confers Cisplatin Resistance in Non‑small Cell Lung Cancer via Targeting of PTEN

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

TGFβ Signaling Confers Sorafenib Resistance via Induction of Multiple RTKs in Hepatocellular Carcinoma Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy